Physician

Min S Kang, MD

According to 2025 Medicare claims, Min Kang, MD (NPI: 1457358749) practices medical oncology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 98506-5028. Kang is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Kang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 632 traditional Medicare patients, billed 100,877 HCPCS/CPT codes, and received $1,732,961 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 967 prescription claims across 170 beneficiaries totaling $2,401,435 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2023 DME data shows 47 claims. Open Payments data shows 10 records totaling $193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $993,480 to $2,401,435. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,504 to $1,297.